Literature DB >> 23165496

Treatment and hematopoietic SCT in aplastic anemia.

J R Passweg, M Aljurf.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23165496     DOI： 10.1038/bmt.2012.229

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  6 in total

Review 1.  Current concepts in the pathophysiology and treatment of aplastic anemia.

Authors:  Neal S Young
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

2.  Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Carlo Dufour; Marta Pillon; Jakob Passweg; Gerard Socié; Andrea Bacigalupo; Genny Franceschetto; Elisa Carraro; Rosi Oneto; Antonio Maria Risitano; Regis Peffault de Latour; André Tichelli; Alicia Rovo; Christina Peters; Britta Hoechsmann; Sujith Samarasinghe; Austin G Kulasekararaj; Hubert Schrezenmeier; Mahmoud Aljurf; Judith Marsh
Journal:  Haematologica       Date:  2014-08-01       Impact factor: 9.941

3.  Improved outcome of haploidentical transplantation in severe aplastic anemia using reduced-intensity fludarabine-based conditioning.

Authors:  Wu Yamei; Luo Rongmu; Cao Yongbin; Si Yingjian; Li Xiaohong; Zhang Xiaomei; Yan Pei; Du Zhenlan; Wang Haitao; Wang Jing; Wang Bojing; Wu Xiaoxiong; Da Wanming
Journal:  Oncotarget       Date:  2017-07-31

Review 4.  Natural Antioxidants in Anemia Treatment.

Authors:  Coralia Cotoraci; Alina Ciceu; Alciona Sasu; Anca Hermenean
Journal:  Int J Mol Sci       Date:  2021-02-13       Impact factor: 5.923

5.  Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.

Authors:  J C Marsh; R M Pearce; M B C Koh; Z Lim; A Pagliuca; G J Mufti; J Perry; J A Snowden; A J Vora; R T Wynn; N Russell; B Gibson; M Gilleece; D Milligan; P Veys; S Samarasinghe; M McMullin; K Kirkland; G Cook
Journal:  Bone Marrow Transplant       Date:  2013-08-05       Impact factor: 5.483

Review 6.  Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.

Authors:  S Gandhi; A G Kulasekararaj; G J Mufti; J C W Marsh
Journal:  Int J Hematol       Date:  2013-04-30       Impact factor: 2.490
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.